AOP Health: Andreas Goppelt appointed Managing Director of OrphaCare
OrphaCare, a global specialist for the development and marketing of medical devices for drug delivery and part of the AOP Health Group, has appointed Andreas Goppelt as its new Managing Director, succeeding Georg Fischer. In this role, the seasoned medical device expert will focus on broadening the company’s strategic scope and driving its next phase of growth. OrphaCare plays a key role in supporting AOP Health’s integrated therapies approach, and the Group’s long-term expansion.
Andreas Goppelt brings more than 25 years of leadership experience across MedTech, biotechnology and the pharmaceutical industry. He has a proven track record of driving innovation, scaling global organizations, and delivering growth in highly regulated healthcare environments.
In his new role, Goppelt will drive OrphaCare’s expansion through a combination of geographic growth and portfolio expansion by advancing a cutting-edge product pipeline with targeted mergers and acquisitions.
Goppelt will prioritize organizational agility, digital transformation, and operational excellence. In parallel he will foster a high-performance culture built on accountability, collaboration, and empowerment.
Improving Patient Care
“With this appointment, we are further strengthening OrphaCare’s development and its contribution to improving patient care in complex and underserved therapeutic areas,” said Martin Steinhart, CEO of AOP Health Group. “OrphaCare is an essential part of our integrated therapies´ approach. Andreas Goppelt brings the experience and strategic perspective needed to further expand this important part of our business.”
“Working at OrphaCare means taking responsibility for patients who often have limited treatment options,” said Goppelt. “This requires not only expertise, but also clarity in how we work together and a shared commitment to making a real difference. My goal is to create an environment where people take ownership and are proud of the impact they have.”
About Andreas Goppelt
Prior to joining OrphaCare, Andreas Goppelt held senior executive roles including Chief Technology Officer and Chief Executive Officer. Most recently, he served at Ottobock, where he led global R&D transformation initiatives and oversaw large-scale international operations. Earlier in his career, he co-founded SWITCH Biotech and held leadership roles at Baxter BioSurgery.
Andreas Goppelt holds a Ph.D. in Biochemistry from the Ludwig-Maximilians-Universität München.
Kontakt
DI Isolde Fally
Isolde.Fally@aop-health.com
+43-676-500 4048
https://www.aop-health.com